Camden National director receives 350-share stock grant

Camden National Corp director Carl John Soderberg reported an equity award of 350 shares of Common Stock, acquired as a grant in lieu of director fees.

Accepted by SEC EDGAR 03/23/2026 - 04:22 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Camden National Corp director Carl John Soderberg reported an equity award of 350 shares of Common Stock, acquired as a grant in lieu of director fees. The shares were awarded at a reportable price of $45.26 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment.

Following this award, Soderberg directly holds 103,122.218 Common shares. A footnote also notes that 910.801 shares have been acquired since the last filing through participation in the company's dividend reinvestment program, illustrating ongoing accumulation of stock through automatic mechanisms rather than open‑market purchases.

Insider Trade Summary

Grant/Award: 350 shares

Grant/Award 1 txn

Insider Soderberg Carl John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common	350	$45.26	$16K

Holdings After Transaction: Common — 103,122.218 shares (Direct)

Footnotes (2)

1. F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
2. F2. Consists of 910.801 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Camden National (CAC) director Carl Soderberg report?

Director Carl John Soderberg reported receiving 350 shares of Camden National Common Stock as an equity grant in lieu of director fees. The award was made under the company’s 2022 Equity and Incentive Plan and is classified as a grant or award acquisition, not an open‑market purchase.

At what price was the Camden National (CAC) director stock grant reported?

The 350-share equity award to director Carl John Soderberg was reported at $45.26 per share. This figure reflects the reportable price used for Form 4 disclosure purposes for the Common Stock received as compensation, not a discretionary market trade executed on an exchange.

How many Camden National (CAC) shares does Carl Soderberg hold after this grant?

After the 350-share grant, Carl John Soderberg directly holds 103,122.218 Camden National Common shares. This total includes his existing holdings plus the new award, providing context for the overall size of his reported ownership stake following the latest Form 4 transaction.

Was the Camden National (CAC) director transaction a market purchase or compensation grant?

The transaction was a compensation-related equity grant, not a market purchase. The 350 shares were acquired in lieu of director fees under Camden National Corporation’s 2022 Equity and Incentive Plan and Amendment, reflecting routine non-cash director compensation rather than an open‑market investment decision.

What role does the dividend reinvestment program play in Carl Soderberg’s Camden National (CAC) holdings?

A footnote explains that 910.801 shares have been acquired since the last filing through the company’s dividend reinvestment program. This program automatically reinvests cash dividends into additional Camden National shares, gradually increasing Soderberg’s ownership without separate open‑market transactions.

How is the Camden National (CAC) equity grant categorized in the Form 4 filing?

The 350-share transaction is coded as “A” for a grant, award, or other acquisition of non-derivative Common Stock. It is described as shares acquired under Camden National Corporation’s 2022 Equity and Incentive Plan and Amendment, specifically in lieu of director fees, indicating standard board compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Soderberg Carl John

(Last) (First) (Middle)

2 ELM STREET

PO BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	03/20/2026		A		350(1)	A	$45.26	103,122.218(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

2. Consists of 910.801 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Remarks:

	Christopher G. Hutchinson, POA	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)